KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Stereotaxis (STXS) EBT Margin (2016 - 2025)

Stereotaxis (STXS) has disclosed EBT Margin for 16 consecutive years, with 87.85% as the latest value for Q3 2025.

  • On a quarterly basis, EBT Margin fell 1885.0% to 87.85% in Q3 2025 year-over-year; TTM through Sep 2025 was 80.1%, a 905.0% increase, with the full-year FY2024 number at 91.91%, down 1033.0% from a year prior.
  • EBT Margin was 87.85% for Q3 2025 at Stereotaxis, down from 45.2% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 17.72% in Q1 2021 to a low of 133.74% in Q2 2024.
  • A 5-year average of 71.67% and a median of 68.98% in 2024 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: crashed -6659bps in 2024, then soared 8854bps in 2025.
  • Stereotaxis' EBT Margin stood at 40.64% in 2021, then plummeted by -50bps to 61.03% in 2022, then plummeted by -90bps to 116.19% in 2023, then fell by -4bps to 120.3% in 2024, then rose by 27bps to 87.85% in 2025.
  • Per Business Quant, the three most recent readings for STXS's EBT Margin are 87.85% (Q3 2025), 45.2% (Q2 2025), and 79.35% (Q1 2025).